Indeed, HOXA5 controls NSCLC cell proliferation by positively regulating the expression of Cdkn1a, encoding the cyclin-dependent kinase inhibitor p21 [90]. The gene discussed is CDKN1A; the disease is non-small cell lung carcinoma.